|
🐜
|
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
9 auth.
J. Krystal,
L. Karper,
J. Seibyl,
G. K. Freeman,
R. Delaney,
J. Bremner,
...
G. Heninger,
M. Bowers,
D. Charney
|
11 |
1994 |
11
🐜
|
|
🐜
|
The Parkinson Progression Marker Initiative (PPMI)
84 auth.
K. Marek,
D. Jennings,
Shirley Lasch,
A. Siderowf,
C. Tanner,
T. Simuni,
Chris Coffey,
K. Kieburtz,
Emily Flagg,
S. Chowdhury,
W. Poewe,
B. Mollenhauer,
P. Klinik,
T. Sherer,
M. Frasier,
...
C. Meunier,
A. Rudolph,
C. Casaceli,
J. Seibyl,
S. Mendick,
N. Schuff,
Ying Zhang,
A. Toga,
K. Crawford,
Alison B. Ansbach,
P. Blasio,
Michele Piovella,
J. Trojanowski,
L. Shaw,
A. Singleton,
K. Hawkins,
J. Eberling,
D. Brooks,
D. Russell,
Laura Leary,
S. Factor,
B. Sommerfeld,
P. Hogarth,
E. Pighetti,
Karen Williams,
D. Standaert,
Stephanie L Guthrie,
R. Hauser,
H. Delgado,
J. Jankovic,
C. Hunter,
M. Stern,
B. Tran,
J. Leverenz,
Marne Baca,
S. Frank,
Cathi A Thomas,
I. Richard,
C. Deeley,
L. Rees,
F. Sprenger,
Elisabeth Lang,
H. Shill,
Sanja Obradov,
Hubert H. Fernandez,
Adrienna Winters,
D. Berg,
K. Gauss,
D. Galasko,
D. Fontaine,
Z. Mari,
M. Gerstenhaber,
D. Brooks,
Sophie Malloy,
P. Barone,
K. Longo,
Tom Comery,
B. Ravina,
I. Grachev,
Kim Gallagher,
Michelle Collins,
K. Widnell,
Suzanne Ostrowizki,
P. Fontoura,
Tony P Ho,
J. Luthman,
M. Brug,
A. Reith,
Peggy Taylor
|
10 |
2011 |
10
🐜
|
|
🐜
|
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
69 auth.
R. Holloway,
I. Shoulson,
K. Kieburtz,
M. Mcdermott,
P. Tariot,
Cornelia L. Kamp,
D. Day,
A. Shinaman,
S. Fahn,
A. Lang,
K. Marek,
J. Seibyl,
W. Weiner,
M. Welsh,
R. Pahwa,
...
S. Coe,
L. Barclay,
L. Sutherland,
K. Hildebrand,
J. Hubble,
C. Weeks,
P. LeWitt,
J. Miyasaki,
J. Duff,
E. Sime,
O. Suchowersky,
M. Stacy,
M. Kurth,
M. Brewer,
M. Harrigan,
D. Russell,
B. Fussell,
B. Ford,
S. Dillon,
J. Hammerstad,
C. Stone,
D. Riley,
P. Rainey,
D. Standaert,
M. Tennis,
F. Wooten,
E. Rost-ruffner,
S. Factor,
D. Brown,
J. Jankovic,
F. Atassi,
R. Kurlan,
I. Gardiner,
M. Panisset,
D. Amyot,
J. Hall,
A. Rajput,
T. Shirley,
R. Rodnitzky,
J. Dobson,
C. Shults,
D. Fontaine,
C. Waters,
S. Schuman,
R. Pfeiffer,
Shirley A. Rast,
B. Pfeiffer,
A. Brocht,
C. Casaceli,
S. Daigneault,
K. Hodgeman,
K. Honsinger,
C. O'Connell,
A. Watts
|
9 |
2000 |
9
🐜
|
|
🐜
|
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
10 auth.
A. Abi-Dargham,
R. Gil,
J. Krystal,
R. M. Baldwin,
J. Seibyl,
Malcom Bowers,
...
C. V. van Dyck,
D. Charney,
R. Innis,
M. Laruelle
|
9 |
1998 |
9
🐜
|
|
🐜
|
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
69 auth.
R. Holloway,
I. Shoulson,
S. Fahn,
K. Kieburtz,
A. Lang,
K. Marek,
M. Mcdermott,
J. Seibyl,
W. Weiner,
B. Musch,
Cornelia L. Kamp,
M. Welsh,
A. Shinaman,
R. Pahwa,
L. Barclay,
...
J. Hubble,
P. LeWitt,
J. Miyasaki,
O. Suchowersky,
M. Stacy,
D. Russell,
B. Ford,
J. Hammerstad,
D. Riley,
D. Standaert,
F. Wooten,
S. Factor,
J. Jankovic,
F. Atassi,
R. Kurlan,
M. Panisset,
A. Rajput,
R. Rodnitzky,
C. Shults,
Giselle Petsinger,
C. Waters,
R. Pfeiffer,
K. Biglan,
Leona D Borchert,
A. Montgomery,
L. Sutherland,
C. Weeks,
M. DeAngelis,
E. Sime,
S. Wood,
C. Pantella,
M. Harrigan,
B. Fussell,
S. Dillon,
Barbara Alexander-Brown,
P. Rainey,
M. Tennis,
E. Rost-ruffner,
Diane L. Brown,
S. Evans,
Debra Berry,
Jean Hall,
T. Shirley,
J. Dobson,
D. Fontaine,
B. Pfeiffer,
A. Brocht,
Susan Bennett,
S. Daigneault,
K. Hodgeman,
C. O'Connell,
Tori Ross,
Karen Richard,
A. Watts
|
9 |
2004 |
9
🐜
|
|
🐜
|
CSF biomarkers of Alzheimer’s disease concord with amyloid-β PETand predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
15 auth.
O. Hansson,
J. Seibyl,
E. Stomrud,
H. Zetterberg,
J. Trojanowski,
T. Bittner,
V. Lifke,
V. Corradini,
U. Eichenlaub,
R. Batrla,
...
K. Buck,
Katharina Zink,
C. Rabe,
K. Blennow,
L. Shaw
|
9 |
2018 |
9
🐜
|
|
🐜
|
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
11 auth.
H. Barthel,
H. Gertz,
S. Dresel,
O. Peters,
P. Bartenstein,
K. Buerger,
...
F. Hiemeyer,
S. Wittemer-Rump,
J. Seibyl,
C. Reininger,
O. Sabri
|
9 |
2011 |
9
🐜
|
|
🐜
|
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography
14 auth.
R. Malison,
L. Price,
R. Berman,
C. Dyck,
G. Pelton,
L. Carpenter,
G. Sanacora,
M. Owens,
C. Nemeroff,
N. Rajeevan,
...
R. M. Baldwin,
J. Seibyl,
R. Innis,
D. Charney
|
9 |
1998 |
9
🐜
|
|
🦁
|
Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease
12 auth.
J. Seibyl,
K. L. Marchek,
D. Quinlan,
K. Sheff,
S. Zoghbi,
Y. Zea‐Ponce,
...
R. Baldwin,
B. Fussell,
Eileen O. Smith,
D. Charney,
P. Hoffer,
R. Innis
|
8 |
1995 |
8
🦁
|
|
🐜
|
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
23 auth.
O. Sabri,
M. Sabbagh,
J. Seibyl,
H. Barthel,
H. Akatsu,
Y. Ouchi,
K. Senda,
S. Murayama,
K. Ishii,
M. Takao,
...
T. Beach,
C. Rowe,
J. Leverenz,
B. Ghetti,
J. Ironside,
A. Catafau,
A. Stephens,
A. Mueller,
N. Koglin,
Anja Hoffmann,
Katrin Roth,
C. Reininger,
W. Schulz-Schaeffer
|
8 |
2015 |
8
🐜
|
|
🐜
|
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
169 auth.
K. Marek,
S. Chowdhury,
A. Siderowf,
Shirley Lasch,
C. Coffey,
C. Caspell-Garcia,
T. Simuni,
D. Jennings,
C. Tanner,
J. Trojanowski,
L. Shaw,
J. Seibyl,
N. Schuff,
A. Singleton,
K. Kieburtz,
...
A. Toga,
B. Mollenhauer,
D. Galasko,
L. Chahine,
D. Weintraub,
T. Foroud,
D. Tosun-Turgut,
K. Poston,
V. Arnedo,
M. Frasier,
T. Sherer,
S. Bressman,
M. Merchant,
W. Poewe,
C. Kopil,
A. Naito,
R. Dorsey,
C. Casaceli,
N. Daegele,
J. Albani,
L. Uribe,
Eric D. Foster,
J. Long,
N. Seedorff,
K. Crawford,
Danielle Smith,
P. Casalin,
G. Malferrari,
C. Halter,
L. Heathers,
D. Russell,
S. Factor,
P. Hogarth,
A. Amara,
R. Hauser,
J. Jankovic,
M. Stern,
Shu‐Ching Hu,
Gretchen Todd,
R. Saunders-Pullman,
I. Richard,
H. Saint‐Hilaire,
K. Seppi,
H. Shill,
Hubert H. Fernandez,
C. Trenkwalder,
W. Oertel,
D. Berg,
Kathrin Brockman,
I. Wurster,
L. Rosenthal,
Yen F. Tai,
N. Pavese,
P. Barone,
S. Isaacson,
A. Espay,
D. Rowe,
M. Brandabur,
J. Tetrud,
G. Liang,
Á. Iranzo,
E. Tolosa,
K. Marder,
Maria de Sanchez,
L. Stefanis,
M. Marti,
J. Martínez,
J. Corvol,
O. Assly,
Salima Brillman,
Nir Giladi,
Debra Smejdir,
Julia Pelaggi,
F. Kausar,
L. Rees,
Barbara Sommerfield,
Madeline Cresswell,
C. Blair,
Karen Williams,
Grace A. Zimmerman,
S. Guthrie,
Ashlee Rawlins,
Leigh Donharl,
C. Hunter,
B. Tran,
A. Darin,
Heli A. Venkov,
Cathi A Thomas,
Raymond James,
B. Heim,
Paul Deritis,
F. Sprenger,
D. Raymond,
D. Willeke,
Zoran Obradov,
J. Mule,
Nancy Monahan,
K. Gauss,
D. Fontaine,
D. Szpak,
Arita McCoy,
Becky Dunlop,
Laura Payne,
Susan Ainscough,
L. Carvajal,
Rebecca Silverstein,
Kristy J. Espay,
Madelaine B. Rañola,
E. Rezola,
H. Santana,
M. Stamelou,
Alicia Garrido,
S. Carvalho,
G. Kristiansen,
Krista Specketer,
Anat Mirlman,
M. Facheris,
H. Soares,
A. Mintun,
J. Cedarbaum,
Peggy Taylor,
L. Slieker,
Brian McBride,
Colin Watson,
Etienne Montagut,
Z. Sheikh,
Baris Bingol,
R. Forrat,
P. Sardi,
T. Fischer,
D. Reith,
J. Egebjerg,
L. Larsen,
N. Breysse,
D. Meulien,
B. Saba,
V. Kiyasova,
C. Min,
Thomas McAvoy,
R. Umek,
P. Iredale,
J. Edgerton,
Demetrio Santi,
C. Czech,
F. Boess,
J. Sevigny,
T. Kremer,
I. Grachev,
K. Merchant,
A. Avbersek,
P. Muglia,
Alexandra Stewart,
R. Prashad,
Johannes Taucher
|
8 |
2018 |
8
🐜
|
|
🐜
|
Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
15 auth.
A. Joshi,
M. Pontecorvo,
C. Clark,
A. Carpenter,
D. Jennings,
C. Sadowsky,
L. Adler,
Karel D. Kovnat,
J. Seibyl,
A. Arora,
...
K. Saha,
J. Burns,
M. Lowrey,
M. Mintun,
D. Skovronsky
|
8 |
2012 |
8
🐜
|
|
🐜
|
[sup 123 I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease
10 auth.
K. Marek,
J. Seibyl,
S. Zoghbi,
Y. Zea‐Ponce,
R. Baldwin,
B. Fussell,
...
D. Charney,
C. Dyck,
P. Hoffer,
R. Innis
|
8 |
1996 |
8
🐜
|
